We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Editas Medicine ... with CRISPR-Cas9 leading the charge.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Prime Medicine ... with CRISPR-Cas9 leading the charge.

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...

This ability to precisely target and cut DNA is the foundation for gene editing applications ... future, CRISPR diagnostics have the potential to transform the field of personalized medicine.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

CTX001 is an ‘ex vivo’ application of gene-editing, in which the technology is used to modify a patient’s own cells outside the body. It uses CRISPR/Cas9 to make a patient’s haematopoietic ...